ALDH2 and lung cancer: Similar to our observations, overexpression of ALDH2 resulted in higher cell proliferation rate, higher clone formation rate, and resistance to 4-hydroperoxycyclophosphamide and doxorubicin in leukemia and lung cancer cell lines [24].